10 Year Cad Risk Reduction After Treatment with Ezetimibe 10 Mg/Day Co-Administered with Statins in Patients with Primary Hypercholesterolemia Who Have Not Responded to Statin Monotherapy. S Bissonnette, R Habib, S Boukas
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.